focus -WSS

focus

author：focus 2025-10-01 00:58:31 - browse：3625

Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a handful of biotech companies are trying to develop next-generation, longer-lasting therapies based on a very different approach: RNA interference.

This Nobel Prize-winning science works by degrading the biological blueprints that RNA use to make proteins — without the genetic instructions, the troublesome proteins are never made and the gene is essentially muted.

If the companies succeed, it would be a significant shift in the obesity treatment revolution, away from weekly drugs targeting hormones to medications that could be given much less frequently — twice a year or even less — and pinpoint genetic contributors to weight.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Ebola vaccine can save some who are already sick, per new study

explore

WSS

A look at other Americans who have crossed into North Korea over the years

Biden administration sends mixed signals on US soldier who crossed into North Korea

Readout Newsletter: Amylyx, Aurinia, and IQVIA

Juul documents reveal insider tactics on political lobbying

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Psychedelics group wrestles with new pharma identity

Flagship, Pfizer team up in deal worth up to $7 billion

In age of alternative facts, a scholarly course on calling out crap

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

How to save PrEP access — and even expand it

Flagship, Pfizer team up in deal worth up to $7 billion

Hepatitis C has a cure — but many Americans still lack access to it

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

focus

Having children helps parents live longer, especially after age 80

15 die by electrocution after transformer explodes in northern India

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Lack of darker skin in textbooks, journals harms patients of color

Congress must protect the remaining independent doctors

ACIP vaccine advisory panel sees its vacancies filled

explore

explore

Wikipedia

Wikipedia